$100.30
-0.37-0.37%
À la fermeture: -
$100.41
0.110.11%
Après les heures de négociation: Nov 14, 7:59 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Citigroup Inc a un objectif de cours consensuel de $97.71 basé sur les évaluations de 19 analystes. Le plus élevé est $134, publié par Morgan Stanley le octobre 15, 2025. Le plus bas est $65, publié par Jefferies le avril 8, 2024. Les 3 évaluations d’analystes les plus récentes ont été publiées par Keefe, Bruyette & Woods, B of A Securities et Barclays le octobre 17, 2025, octobre 15, 2025 et octobre 15, 2025, respectivement. Avec un objectif de cours moyen de $117.67 entre Keefe, Bruyette & Woods, B of A Securities et Barclays, il existe une variation implicite de 17.19% upside pour Citigroup Inc selon ces dernières évaluations d’analystes.
Sociétés d'analyse émettant des recommandations1
Keefe, Bruyette & Woods
B of A Securities
Barclays
TD Cowen
Piper Sandler
1calculé à partir des notes des analystes
Notes d'analystes pour Citigroup
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 17.52% | Keefe, Bruyette & Woods | $112 → $118 | Maintains | Outperform | |||
10/15/2025 | 19.51% | B of A Securities | $115 → $120 | Maintains | Buy | |||
10/15/2025 | 14.53% | Barclays | $100 → $115 | Maintains | Overweight | |||
10/15/2025 | 9.55% | TD Cowen | $105 → $110 | Maintains | Hold | |||
10/15/2025 | 9.55% | Piper Sandler | $107 → $110 | Maintains | Overweight | |||
10/15/2025 | 33.45% | Morgan Stanley | $129 → $134 | Maintains | Overweight | |||
09/29/2025 | 28.47% | Morgan Stanley | $107 → $129 | Maintains | Overweight | |||
09/24/2025 | 11.54% | Truist Securities | $105 → $112 | Maintains | Buy | |||
09/23/2025 | 22.5% | Oppenheimer | $124 → $123 | Maintains | Outperform | |||
09/16/2025 | 24.49% | Wells Fargo | $115 → $125 | Maintains | Overweight | |||
09/03/2025 | 4.57% | Truist Securities | $99 → $105 | Maintains | Buy | |||
07/30/2025 | 23.49% | Oppenheimer | $123 → $124 | Maintains | Outperform | |||
07/16/2025 | 14.53% | Wells Fargo | $110 → $115 | Maintains | Overweight | |||
07/16/2025 | -1.4% | Truist Securities | $93 → $99 | Maintains | Buy | |||
07/16/2025 | 3.58% | Piper Sandler | $84 → $104 | Maintains | Overweight | |||
07/16/2025 | 22.5% | Oppenheimer | $107 → $123 | Maintains | Outperform | |||
07/16/2025 | -0.41% | Barclays | $95 → $100 | Maintains | Overweight | |||
07/16/2025 | -5.39% | TD Cowen | $85 → $95 | Maintains | Hold | |||
07/16/2025 | 6.56% | Morgan Stanley | $103 → $107 | Maintains | Overweight | |||
07/15/2025 | -11.36% | UBS | $89 → $89 | Maintains | Neutral | |||
07/09/2025 | -7.38% | Truist Securities | $84 → $93 | Maintains | Buy | |||
07/03/2025 | 2.58% | Morgan Stanley | $94 → $103 | Maintains | Overweight | |||
07/02/2025 | -4.39% | Goldman Sachs | $85 → $96 | Maintains | Buy | |||
07/02/2025 | -23.31% | Evercore ISI Group | $76 → $77 | Maintains | In-Line | |||
06/26/2025 | -0.41% | B of A Securities | $89 → $100 | Maintains | Buy | |||
06/23/2025 | -6.38% | Morgan Stanley | $90 → $94 | Maintains | Overweight | |||
06/10/2025 | -15.35% | Goldman Sachs | $75 → $85 | Maintains | Buy | |||
04/28/2025 | -6.38% | Oppenheimer | $91 → $94 | Maintains | Outperform | |||
04/16/2025 | -22.32% | RBC Capital | $85 → $78 | Maintains | Outperform | |||
04/16/2025 | -8.38% | Keefe, Bruyette & Woods | $96 → $92 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -23.31% | Piper Sandler | $83 → $77 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -21.32% | Truist Securities | $84 → $79 | Maintains | Buy | |||
04/04/2025 | -16.34% | Truist Securities | $85 → $84 | Maintains | Buy | |||
04/03/2025 | -24.81% | JP Morgan | $85.5 → $75.5 | Maintains | Neutral | |||
04/02/2025 | -11.36% | B of A Securities | $90 → $89 | Maintains | Buy | |||
04/01/2025 | -24.31% | Evercore ISI Group | $79 → $76 | Maintains | In-Line | |||
03/19/2025 | -20.33% | Goldman Sachs | $90 → $80 | Maintains | Buy | |||
03/13/2025 | 8.55% | Morgan Stanley | $110 → $109 | Maintains | Overweight | |||
03/10/2025 | -10.37% | B of A Securities | $100 → $90 | Maintains | Buy | |||
02/18/2025 | -0.41% | B of A Securities | $95 → $100 | Maintains | Buy | |||
01/29/2025 | -10.37% | Goldman Sachs | $86 → $90 | Maintains | Buy | |||
01/16/2025 | -15.35% | RBC Capital | $74 → $85 | Maintains | Outperform | |||
01/16/2025 | -13.36% | Argus Research | $72 → $87 | Maintains | Buy | |||
01/16/2025 | 8.55% | Morgan Stanley | $104 → $109 | Maintains | Overweight | |||
01/16/2025 | -21.32% | Evercore ISI Group | $69 → $79 | Maintains | In-Line | |||
01/16/2025 | -14.35% | Goldman Sachs | $77 → $86 | Maintains | Buy | |||
01/16/2025 | -8.38% | Keefe, Bruyette & Woods | $85 → $92 | Maintains | Outperform | |||
01/16/2025 | -17.34% | Piper Sandler | $80 → $83 | Reiterates | Overweight → Overweight | |||
01/07/2025 | -5.39% | B of A Securities | $90 → $95 | Maintains | Buy | |||
01/07/2025 | -15.35% | Truist Securities | — | → $85 | Initiates | → Buy | ||
01/06/2025 | -5.39% | Barclays | $70 → $95 | Upgrade | Equal-Weight → Overweight | |||
01/03/2025 | 9.55% | Wells Fargo | $95 → $110 | Maintains | Overweight | |||
01/03/2025 | -15.35% | Keefe, Bruyette & Woods | $82 → $85 | Maintains | Outperform | |||
01/03/2025 | 1.58% | Oppenheimer | $110 → $102 | Maintains | Outperform | |||
01/02/2025 | -31.28% | Evercore ISI Group | $66 → $69 | Maintains | In-Line | |||
12/06/2024 | -19.33% | Goldman Sachs | $72 → $81 | Maintains | Buy | |||
12/03/2024 | -18.33% | Keefe, Bruyette & Woods | $70 → $82 | Upgrade | Market Perform → Outperform | |||
12/03/2024 | -20.33% | Piper Sandler | $73 → $80 | Maintains | Overweight | |||
12/02/2024 | -10.37% | B of A Securities | $78 → $90 | Maintains | Buy | |||
11/15/2024 | -5.39% | Wells Fargo | $85 → $95 | Maintains | Overweight | |||
11/05/2024 | 6.56% | Oppenheimer | $91 → $107 | Maintains | Outperform | |||
10/16/2024 | -30.29% | Barclays | $63 → $70 | Maintains | Equal-Weight | |||
10/16/2024 | -36.26% | Evercore ISI Group | $63 → $64 | Maintains | In-Line | |||
10/16/2024 | -9.37% | Oppenheimer | $92 → $91 | Maintains | Outperform | |||
10/16/2024 | -18.33% | Morgan Stanley | $86 → $82 | Maintains | Overweight | |||
10/16/2024 | -22.32% | B of A Securities | $77 → $78 | Maintains | Buy | |||
10/02/2024 | -8.38% | Oppenheimer | $87 → $92 | Maintains | Outperform | |||
09/30/2024 | -14.35% | Morgan Stanley | $79 → $86 | Maintains | Overweight | |||
09/11/2024 | -29.29% | Goldman Sachs | $75 → $71 | Maintains | Buy | |||
07/30/2024 | -21.32% | Morgan Stanley | $66 → $79 | Maintains | Overweight | |||
07/15/2024 | -33.27% | BMO Capital | $65 → $67 | Maintains | Market Perform | |||
07/15/2024 | -28.29% | Argus Research | $70 → $72 | Maintains | Buy | |||
07/15/2024 | -27.3% | Piper Sandler | $70 → $73 | Reiterates | Overweight → Overweight | |||
07/15/2024 | -14.35% | Oppenheimer | $85 → $86 | Maintains | Outperform | |||
07/15/2024 | -34.27% | Morgan Stanley | $65 → $66 | Maintains | Overweight | |||
07/03/2024 | -38.25% | Evercore ISI Group | $60 → $62 | Maintains | In-Line | |||
06/20/2024 | -35.27% | Morgan Stanley | $65 → $65 | Maintains | Overweight | |||
06/20/2024 | -34.27% | RBC Capital | $66 → $66 | Reiterates | Outperform → Outperform | |||
06/20/2024 | -31.28% | Keefe, Bruyette & Woods | $66 → $69 | Maintains | Market Perform | |||
06/17/2024 | -34.27% | RBC Capital | $63 → $66 | Maintains | Outperform | |||
04/30/2024 | -14.35% | Oppenheimer | $87 → $86 | Maintains | Outperform | |||
04/15/2024 | -37.26% | BMO Capital | $61 → $63 | Maintains | Market Perform | |||
04/15/2024 | -30.29% | Argus Research | $60 → $70 | Maintains | Buy | |||
04/15/2024 | -30.29% | Piper Sandler | $67 → $70 | Maintains | Overweight | |||
04/15/2024 | -13.36% | Oppenheimer | $88 → $87 | Maintains | Outperform | |||
04/08/2024 | -35.27% | Jefferies | $56 → $65 | Maintains | Hold | |||
04/05/2024 | -34.27% | Keefe, Bruyette & Woods | $54 → $66 | Maintains | Market Perform | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
04/01/2024 | -20.33% | Wells Fargo | $80 → $80 | Maintains | Overweight | |||
03/28/2024 | -30.29% | HSBC | $61 → $70 | Maintains | Buy | |||
03/25/2024 | -20.33% | Wells Fargo | $70 → $80 | Maintains | Overweight | |||
03/19/2024 | -12.36% | Oppenheimer | $95 → $88 | Maintains | Outperform | |||
03/15/2024 | -32.28% | Goldman Sachs | $55 → $68 | Maintains | Buy | |||
03/14/2024 | -32.28% | Goldman Sachs | $55 → $68 | Upgrade | Neutral → Buy | |||
02/14/2024 | -37.26% | Piper Sandler | $56 → $63 | Upgrade | Neutral → Overweight | |||
01/30/2024 | -5.39% | Oppenheimer | $93 → $95 | Maintains | Outperform | |||
01/30/2024 | -35.27% | Morgan Stanley | $46 → $65 | Upgrade | Underweight → Overweight | |||
01/16/2024 | -7.38% | Oppenheimer | $85 → $93 | Maintains | Outperform | |||
01/16/2024 | -44.23% | Piper Sandler | $53 → $56 | Maintains | Neutral | |||
01/10/2024 | — | BMO Capital | — | Downgrade | Outperform → Market Perform |
FAQ
Quel est le cours indicatif de l'action Citigroup (C) ?
Le dernier objectif de prix pour Citigroup (NYSE:C) a été rapporté par Keefe, Bruyette & Woods le octobre 17, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $118.00 s'attendant à ce que C se rise dans les 12 prochains mois (un possible changement de 17.52% upside). 59 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Citigroup (C) ?
La dernière note d'analyste pour Citigroup (NYSE:C) a été fournie par Keefe, Bruyette & Woods, et Citigroup maintenu leur note outperform.
Quand a eu lieu la dernière mise à niveau pour Citigroup (C) ?
La dernière amélioration pour Citigroup Inc a eu lieu le janvier 6, 2025 lorsque Barclays a augmenté leur objectif de prix à $95. Barclays avait précédemment an equal-weight pour Citigroup Inc.
Quand a eu lieu la dernière dégradation pour Citigroup (C) ?
La dernière réduction pour Citigroup Inc a eu lieu le janvier 10, 2024 lorsque BMO Capital a changé leur objectif de prix de N/A à N/A pour Citigroup Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Citigroup (C) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Citigroup, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Citigroup a été déposée le octobre 17, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 17, 2026.
La note d'analyste pour Citigroup (C) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Citigroup (C) était un maintenu avec un objectif de prix de $112.00 à $118.00. Le prix actuel de Citigroup (C) est de $100.41, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.